Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

about

Mechanisms of simvastatin-induced vasodilatation of rat superior mesenteric arteries.New directions for pharmacotherapy in the treatment of acute coronary syndrome.

P2860

Q37288422-F6FA113F-271C-4ECC-A4DD-D62FA17341BA Q38817144-FAF7074C-1D71-472C-B25C-8B8E09521491

P2860

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

Item

http://www.wikidata.org/entity/Q38446859

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

@en

type

Item

label

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

@en

prefLabel

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

@en

P1476

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

@en

P2860

NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe

Simvastatin with or without ezetimibe in familial hypercholesterolemia

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly.

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada

P304

1255-1262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1041504

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert A. Hegele

Steven E Gryn

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275662509

http://www.w3.org/2001/XMLSchema#string

P698

25920750

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

about

P2860

P2860

Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921